Marisa Verner
Physician Assistant · Kittanning, PANPI 1093496374
Payments from drug & device makers
Across 277 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$995
- Sanofi$558
- Teva Pharmaceuticals USA, Inc.$351
- Lundbeck LLC$298
- Jazz Pharmaceuticals Inc.$282
- Pfizer$255
- plus $3K from 32 others
What the payments were for
- Food & beverage$5,28397%
- Education$1773%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $995 |
| Sanofi | 7 | $558 |
| Teva Pharmaceuticals USA, Inc. | 18 | $351 |
| Lundbeck LLC | 15 | $298 |
| Jazz Pharmaceuticals Inc. | 12 | $282 |
| Pfizer | 16 | $255 |
| Genentech USA, Inc. | 10 | $212 |
| Avadel CNS Pharmaceuticals, LLC | 17 | $201 |
| Novartis | 20 | $199 |
| Eisai Inc. | 11 | $197 |
| Otsuka America Pharmaceutical, Inc. | 9 | $173 |
| Lilly USA, LLC | 8 | $171 |
| Biogen | 8 | $163 |
| AstraZeneca | 7 | $139 |
| Tanabe Pharma America, Inc. | 6 | $136 |
| UCB, Inc. | 6 | $127 |
| Acadia Pharmaceuticals Inc | 6 | $119 |
| Bristol Myers Squibb | 5 | $87 |
| SK Life Science, Inc. | 4 | $83 |
| Neurocrine Biosciences, Inc. | 4 | $77 |
| EMD Serono, Inc. | 3 | $63 |
| Argenx US, Inc. | 3 | $60 |
| Sumitomo Pharma America, Inc. | 4 | $60 |
| Amgen | 3 | $52 |
| TG Therapeutics, Inc. | 2 | $51 |
| Acorda Therapeutics, Inc | 3 | $47 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $36 |
| MDD US Operations, LLC | 1 | $32 |
| Grifols USA, LLC | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Impel Pharmaceuticals Inc. | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| Neurelis, Inc. | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $23 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
| GE HealthCare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,460 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 16 | $114,869 |
| AubagioTeriflunomide | 11 | $96,223 |
| AustedoDeutetrabenazine | 12 | $86,414 |
| UbrelvyUbrogepant | 60 | $74,291 |
| Aimovig AutoinjectorErenumab-Aooe | 87 | $63,906 |
| Nurtec OdtRimegepant Sulfate | 38 | $54,264 |
| QuliptaAtogepant | 46 | $53,354 |
| NuedextaDextromethorphan Hbr/Quinidine | 39 | $39,646 |
| Dimethyl Fumarate | 18 | $37,346 |
| BotoxOnabotulinumtoxina | 23 | $35,018 |
| RytaryCarbidopa/Levodopa | 22 | $23,445 |
| HorizantGabapentin Enacarbil | 29 | $22,201 |
| KeppraLevetiracetam | 18 | $20,223 |
| NeuproRotigotine | 12 | $20,204 |
| BriviactBrivaracetam | 18 | $20,048 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta, Botox | $995 | $162,663129 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $77 | $114,86916 claims |
| SanofiAubagio | $558 | $96,22311 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $351 | $86,41412 claims |
| PfizerNurtec Odt, Dilantin | $255 | $56,43654 claims |
| UCB, Inc.Neupro, Briviact, Nayzilam | $127 | $50,60846 claims |
| Amneal Pharmaceuticals LLCRytary, Pyridostigmine Bromide | $23 | $25,76249 claims |
| Eisai Inc.Fycompa | $197 | $13,71612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Kittanning
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.